CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 5 enrolled
Drug / intervention
5% tea tree oil nasal ointmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01214395
NCT01214395Phase 2Completed
CompareCT.gov

An Investigator Blinded Controlled Study of the Nasal Application of 5% Tea Tree Oil (TTO) for the Prevention of Catheter-associated Infections in Renal Dialysis Patients

PathWest Laboratory Medicine WA·interventional·Posted Oct 5, 2010·Updated Aug 3, 2012

In Brief

A Phase 2 clinical trial evaluating 5% tea tree oil nasal ointment for End Stage Renal Failure on Dialysis. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This study will compare the use of tea tree oil as a topical nasal antiseptic to prevent infections in patients that need renal dialysis. A maximum of fifty subjects will be recruited and will be assessed for signs of infection once per week for the first 6 weeks and then every 4 weeks until week 26. They will also be checked for nasal carriage of 'Golden Staph' when they enroll in the trial. The subjects will complete the trial if they have 26 weeks infection-free or if they have an infection during that period

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Renal Failure on Dialysis
CountriesAustralia
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 5, 2010
Enrollment StartJun 1, 2010
Primary CompletionNov 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 15.7 years ago

Interventions

5% tea tree oil nasal ointmentdrug

daily for 5 days then weekly for 6 months